2010
DOI: 10.2174/138620710791292949
|View full text |Cite
|
Sign up to set email alerts
|

An Instrument-Based Screening Assay for DNA-Targeted Anticancer Drugs Using Resonance Light Scattering

Abstract: DNA is a valid drug target for development of target-based therapeutics against cancer. Screening DNA-targeted anticancer drugs is a key process for the research and development of new anticancer drugs. The traditional anticancer drug screening methods, including animal experiments and cell-based screening assays, have unavoidable drawbacks. In this contribution, the new instrument-based screening assay for DNA-targeted anticancer drugs in vitro using resonance light scattering (RLS) technique was proposed. Th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…[20][21][22][23][24][25][26][27][28][29] In our laboratory, we have successfully introduced it into the screening of anticancer drugs. [30][31][32][33] In this work, a novel resonance light scattering amplification system was developed to detect trace amounts of BD in surface water. In the presence of CTMAB, small concentration changes of BD would induce an obvious increase of RLS intensity.…”
Section: Introductionmentioning
confidence: 99%
“…[20][21][22][23][24][25][26][27][28][29] In our laboratory, we have successfully introduced it into the screening of anticancer drugs. [30][31][32][33] In this work, a novel resonance light scattering amplification system was developed to detect trace amounts of BD in surface water. In the presence of CTMAB, small concentration changes of BD would induce an obvious increase of RLS intensity.…”
Section: Introductionmentioning
confidence: 99%